SGLT-2 inhibitors: new horizons for rheumatologists.
Katherine ChakrabartiW Joseph McCune
Published in: Current opinion in rheumatology (2024)
Small studies have shown that SGLT2 inhibitors can been utilized safely and efficaciously in patients with lupus nephritis. Additional research is needed to identify where these medications fit into the rheumatology treatment armamentarium.